Stay updated on Pembrolizumab for HNSCC Residual Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.

Latest updates to the Pembrolizumab for HNSCC Residual Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now lists Revision: v3.6.3, replacing the previous Revision: v3.6.2; this reflects a small software version update tied to the page rather than substantive content changes.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2. This indicates an updated version of the ClinicalTrials.gov record, suggesting minor edits or corrections to the study information.SummaryDifference0.1%

- Check40 days agoChange DetectedEnrollment status was updated to no longer recruiting participants. New navigation items such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.6%

- Check47 days agoChange DetectedA page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor patch to the ClinicalTrials.gov page with potential small fixes or improvements without changing the study details.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a minor platform/template update to the page. No changes to study data or content are introduced.SummaryDifference0.1%

- Check83 days agoChange DetectedA new page revision tag, v3.5.3, was added and the previous revision tag, v3.5.2, was removed. This reflects a metadata update to the page rather than a change to study content or results.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.